KYORIN Holdings, Inc. (4569.T) JPX

1,151.00

-47(-3.92%)

Updated at June 03 12:41PM

Currency In JPY

Key Executives

Name	Title	Year Born
Yutaka Ogihara	President, Chief Executive Officer & Chairman	1967
Makoto Yanai	Executive Officer & Deputy GM of Business Development Division	N/A
Junichi Ishiyama	Managing Executive Officer, CSO & Head of Drug Discovery Div.	N/A
Katsuhiro Hamada	Executive Officer & GM of Reliability Assurance Headquarters	N/A
Kenichi Nakamura	Corporate Officer & President of KYORIN Pharmaceutical Group Facilities Co., Ltd.	N/A
Michiro Onota	Exe. Director, Mng. Corp. Off., CMO, Chairman of KYORIN Pharmaceutical Grp. Facilities Co., Ltd	1960
Yasuji Kurose	CFO, CSO, Managing Executive Officer, Director of Corporate Planning & Executive Director	1970
Noriaki Tamura	Managing Executive Officer, Chief Commercial Officer & GM of Pharmaceutical Sales Division	N/A
Kimiya Masada	Corporate Officer & Director of Product Strategy	N/A
Kiyoo Uehara	Managing Executive Officer, CHRO & General Affairs Manager	N/A
Takaaki Kaji	Senior Managing Executive Officer & Chief Business Development Officer	N/A

Name

Title

Pay

Year Born

Yutaka Ogihara

President, Chief Executive Officer & Chairman

1967

Makoto Yanai

Executive Officer & Deputy GM of Business Development Division

N/A

Junichi Ishiyama

Managing Executive Officer, CSO & Head of Drug Discovery Div.

N/A

Katsuhiro Hamada

Executive Officer & GM of Reliability Assurance Headquarters

N/A

Kenichi Nakamura

Corporate Officer & President of KYORIN Pharmaceutical Group Facilities Co., Ltd.

N/A

Michiro Onota

Exe. Director, Mng. Corp. Off., CMO, Chairman of KYORIN Pharmaceutical Grp. Facilities Co., Ltd

1960

Yasuji Kurose

CFO, CSO, Managing Executive Officer, Director of Corporate Planning & Executive Director

1970

Noriaki Tamura

Managing Executive Officer, Chief Commercial Officer & GM of Pharmaceutical Sales Division

N/A

Kimiya Masada

Corporate Officer & Director of Product Strategy

N/A

Kiyoo Uehara

Managing Executive Officer, CHRO & General Affairs Manager

N/A

Takaaki Kaji

Senior Managing Executive Officer & Chief Business Development Officer

N/A

Description

KYORIN Holdings, Inc., through its subsidiaries, researches and develops, produces, and sells ethical and generic drugs in Japan and internationally. The company offers Flutiform, a drug for the treatment of asthma; Desalex, an antiallergic agent; Beova, Uritos, and Imidafenacin KYORIN therapeutic agents for overactive bladder; Lasvic, a quinolone synthetic antibacterial agent; Pentasa, a remedy for ulcerative colitis/Crohn's disease; Nasonex, an allergic rhinitis therapeutic agent; and Kipres, a leukotriene receptor antagonist anti-bronchial asthma and allergic rhinitis drug. It also provides Mucodyne, a mucoregulating drug; Montelukast KM, a drug for the treatment of bronchial asthma and allergic rhinitis; GeneSoC, a real-time PCR system; Rubysta, a disinfectant cleaner; Milton, a disinfectant; over-the-counter drugs; prescription medicines and quasi-drugs, diagnostics, and industrial chemicals; and reagents and intermediates. In addition, the company offers subcontracted drug manufacturing services. Further, it is involved in the discovery and evaluation of candidate compounds; and research and analysis of other companies' technologies and collection of information concerning clinical trial. KYORIN Holdings, Inc. was founded in 1923 and is based in Tokyo, Japan.